Abstract
Bone density testing has achieved a prominent role in the evaluation of patients with or at risk for osteoporosis. The original bone methods for measuring bone density were developed several decades ago. The transition of these technologies from the research setting to the patient care arena began as the relationships between bone density and fracture risk were defined and when a definition of postmenopausal osteoporosis, based on bone density values, was provided. The availability of treatments to increase bone density and reduce fracture risk propelled bone density testing into the clinical limelight. Clinical guidelines advocate widespread use of bone density testing, and indications for osteoporosis treatment are now based on bone density values. The number of bone density machines in clinical use has markedly increased in the past 5 years. Testing is no longer confined to the specialist’ s office or radiology centers. Machines are in primary care clinics and in small communities, and testing is available in pharmacies and grocery stores and at health fairs. New technologies and devices have been developed, with each providing different types of information. An international society now exists to address the needs of the clinical bone density community.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blake GM, Fogelman I: Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med 1997, 27:210–228.
Njeh CF, Boivin CM, Langton CM: The role of ultrasound in the assessment of osteoporosis: a review. Osteoporos Int 1997, 7:7–22.
Kanis JA: Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359:1929–1936.
Cummings SR, Black DM, Nevitt MC, et al: Bone density at various sites for prediction of hip fractures.The Study of Osteoporotic Fractures Research Group. Lancet 1993, 341:72–75.
Marshall D, Johnell O, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312:1254–1259.
Kanis JA, Johnell O, Oden A, et al.: Ten-year probability of osteoporotic fracture according to BMD and diagnostic thresholds. Osteoporos Int 2001, 12:989–995.
Ross PD, Davis JW, Epstein RS, Wasnich RD: Pre-existing fractures in bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991, 114:914–923.
National Osteoporosis Foundation: Physician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: NOF, 1998.
Hodgson SF, Watts NB, Bilezikian JP, et al.: American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. Endocr Pract 2001, 7:293–312.
Gallagher JC, Ettinger B, Gass MLS, et al: Management of postmenopausal osteoporosis: Position statement of the North American Menopause Society. Menopause 2002, 9:84–101.
Kanis JA, Gluer C-C: An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 2000, 11:192–202.
Looker AC, Orwoll ES, Johnston CC, et al.: Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 1997, 12:1761–1768.
Faulkner KG, von Stetten E, Miller P: Discordance in patient classification using T-scores. J Clin Densitom 1999,2:343–350.
Hamdy RC, Petak SM, Lenchik L: Which central dual x-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis? J Clin Densitom 2002, 5(3S):S11–S18.
De Laet CE, Van Hout BA, Burger H, et al: Hip fracture in elderly men and women: validation in the Rotterdam Study. J Bone Miner Res 1998, 13:1587–1593.
Binkley NC, Schmeer P, Wasnich RD, Lenchik L: What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom 2002, 5(3S):S19–S28.
Gluer C-C: Monitoring skeletal changes by radiological techniques. J Bone Miner Res 1999, 14:1952–1962.
Lenchik L, Kiebzak GM, Blunt BA: What is the role of serial bone mineral density measurements in patient management? J Clin Densitom 2002, 5(3S):S29–S38.
Liberman UA, Weiss SR, Broil JL: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995, 333:1437–1443.
Miller PD, Njeh CF, Jankowski LG, Lenchik L: International Society for Clinical Densitometry Position Development Panel and Scientific Advisory Committee. What are the standards by which bone mass measurement at peripheral skeletal sites should be used in the diagnosis of osteoporosis? J Clin Densitom 2002, 5(suppl):S39–S45.
Watts NB: Understanding the Bone Mass Measurement Act. J Clin Densitom 1999, 2:211–217.
US Preventive Services Task Force: Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002, 137:526–528.
Greenspan SL, von Stetten E, Emond SK, et al.: Instant vertebral assessment: a noninvasive dual x-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis. J Clin Densitom 2001, 4:373–380.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
McClung, M.R. (2003). Bone Densitometry in Osteoporosis Care. In: Orwoll, E.S. (eds) Atlas of Osteoporosis. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4561-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4561-0_8
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-4563-4
Online ISBN: 978-1-4757-4561-0
eBook Packages: Springer Book Archive